Fields

Oncology Research

Oncology research deciphers the molecular origins of cancer, develops new therapeutic strategies, and seeks to prevent cancer recurrence. Pan-cancer genomic atlases have catalogued the driver mutations, mutational signatures, and chromosomal rearrangements across all major cancer types, enabling precision oncology drug matching. Immune checkpoint inhibitors blocking PD-1/PD-L1 and CTLA-4 have transformed outcomes in melanoma, lung cancer, and bladder cancer. Liquid biopsy captures circulating tumor DNA from blood for minimal residual disease monitoring and early detection. FLASH radiotherapy delivers therapeutic doses in milliseconds, sparing normal tissue by exploiting oxygen depletion kinetics. CAR-T cell therapies are expanding from blood cancers into solid tumor targets through next-generation antigen targeting and engineering strategies.

Details

Avg Funding

$860K

Key Technologies

Single-Cell Multi-OmicsImmune Checkpoint InhibitorsctDNA SequencingCAR-T EngineeringFLASH Radiotherapy

Subfields

Tumor ImmunologyCancer GenomicsTherapeutic ResistanceLiquid BiopsyRadiobiology

Top Institutions

MD Anderson Cancer CenterMemorial Sloan KetteringFrancis Crick InstituteInstitute Gustave RoussyPrincess Margaret Cancer Centre